More recently, PTEN loss has been analyzed in human T-ALL samples displaying the stem cell leukemia (SCL)/TAL1 interrupting locus (STIL) protein/TAL1 fusion product [67] that were xenografted in mice and compared with specimens collected at diagnosis [68]. This evidence concerns the gene PTEN and acute lymphoblastic leukemia.